In Europe, 550 healthy volunteers from Spain, Germany and the Netherlands are participating in a phase 2 clinical trial to test the candidate vaccine from the pharmaceutical company Janssen, owned by the Johnson & Johnson company.
Key tests to determine the effectiveness of immunization that could fight covid-19.
Pau Mosquera was in Madrid with one of the volunteers, a resident of Mexican origin, and he brings us the details in this report.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/K6ONA4VKB25YUMAOAMFUXEWFBA.jpg)
